GlassScriptPhysician profile
Edward L Salerno
NPI 1912970344
$154,043.27
in general payments reported to CMS, 2019-2025
51 companies · $5,224 in 2025
The $5,224 reported for 2025 was more than what 88% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $29K · 2021: $36K · 2022: $23K · 2023: $34K · 2024: $6,649 · 2025: $5,224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $31K · Food and Beverage: $14K · Education: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $31,175.00 |
| Food and Beverage | $14,197.91 |
| Education | $117.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $126,344.07 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $5,371.48 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $4,818.31 | 2019-2025 | Breztri, Fasenra, Airsupra |
| Takeda Pharmaceuticals U.S.A., INC. | $2,180.08 | 2022-2025 | Glassia |
| Inspire Medical Systems, INC. | $1,742.55 | 2019-2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,629.30 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Viiv Healthcare Company | $1,600.00 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $1,092.06 | 2019-2025 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $1,013.53 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| United Therapeutics Corporation | $995.46 | 2021-2025 | Tyvaso, Tyvaso |
| Grifols USA, LLC | $681.34 | 2019-2025 | Prolastin-C Liquid |
| Insmed, INC. | $630.40 | 2020-2025 | Arikayce, Brinsupri |
| Philips North America LLC | $561.49 | 2019-2025 | Vest Therapy Und |
| Merck Sharp & Dohme LLC | $533.82 | 2019-2025 | Winrevair, Zerbaxa, Belsomra |
| Genzyme Corporation | $504.78 | 2019-2025 |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $425.32 | 2019-2024 | Yupelri |
| Amgen INC. | $315.16 | 2021-2025 | Tezspire |
| Jazz Pharmaceuticals INC. | $308.06 | 2019-2025 | |
| Axsome Therapeutics, INC. | $259.15 | 2022-2024 | Sunosi |
| Electromed, INC. | $259.08 | 2023-2025 | Smartvest |
| Janssen Pharmaceuticals, INC | $254.95 | 2021-2024 | Xarelto |
| Inogen, INC. | $226.50 | 2024-2025 | |
| Verona Pharma, INC. | $208.39 | 2025 | Ohtuvayre |
| Intuitive Surgical, INC. | $192.06 | 2024 | |
| Genentech USA, INC. | $168.01 | 2019-2023 | Xolair |
| Ethicon INC. | $145.67 | 2019 | |
| Viatris Specialty LLC | $133.19 | 2025 | Yupelri |
| Amarin Pharma, INC. | $125.05 | 2021 | |
| Noctrix Health, INC. | $120.98 | 2025 | Nidra |
| Covis Pharma Gmbh | $115.02 | 2022 | |
| Resmed Corp | $110.48 | 2022-2025 | |
| Baxter Healthcare | $109.74 | 2023-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System, Hillrom - Vest System Model 105 Home Care |
| Advanced Respiratory, INC | $106.88 | 2019-2020 | |
| Circassia INC. | $82.59 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $82.31 | 2019-2020 | |
| Medtronic, INC. | $80.42 | 2024 | Nuvent |
| Avadel Cns Pharmaceuticals, LLC | $75.32 | 2023-2024 | Lumryz |
| Sunovion Pharmaceuticals INC. | $72.70 | 2019 | |
| Shire North American Group INC | $67.12 | 2019 | |
| Harmony Biosciences LLC | $46.99 | 2023-2024 | Wakix |
| Vapotherm INC | $38.41 | 2022 | |
| Paratek Pharmaceuticals, INC. | $34.32 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $33.35 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $29.16 | 2021 | |
| Allergan, INC. | $23.90 | 2019 | |
| Vifor Pharma, INC. | $19.66 | 2024 | Zemaira |
| La Jolla Pharmaceutical Company | $17.92 | 2019 | |
| Irhythm Technologies, INC. | $15.59 | 2021 | |
| Boston Scientific Corporation | $15.13 | 2021 | |
| Lilly USA, LLC | $14.02 | 2025 | Zepbound |
| Pulmonx Corporation | $12.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Salerno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.